199 related articles for article (PubMed ID: 16670269)
1. Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability.
Wunderlich M; Krejci O; Wei J; Mulloy JC
Blood; 2006 Sep; 108(5):1690-7. PubMed ID: 16670269
[TBL] [Abstract][Full Text] [Related]
2. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
Miller JD; Stacy T; Liu PP; Speck NA
Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585
[TBL] [Abstract][Full Text] [Related]
3. Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias.
Viswanatha DS; Chen I; Liu PP; Slovak ML; Rankin C; Head DR; Willman CL
Blood; 1998 Mar; 91(6):1882-90. PubMed ID: 9490670
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of genes regulated in acute myelomonocytic leukemia with and without inv(16)(p13q22) using microarray techniques, real-time PCR, immunohistochemistry, and flow cytometry immunophenotyping.
Sun X; Zhang W; Ramdas L; Stivers DN; Jones DM; Kantarjian HM; Estey EH; Vadhan-Raj S; Medeiros LJ; Bueso-Ramos CE
Mod Pathol; 2007 Aug; 20(8):811-20. PubMed ID: 17571080
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22).
Zhao W; Claxton DF; Medeiros LJ; Lu D; Vadhan-Raj S; Kantarjian HM; Nguyen MH; Bueso-Ramos CE
Am J Surg Pathol; 2006 Nov; 30(11):1436-44. PubMed ID: 17063086
[TBL] [Abstract][Full Text] [Related]
6. Detection of CBFbeta/MYH11 fusion transcripts in acute myeloid leukemia: heterogeneity of cytological and molecular characteristics.
Costello R; Sainty D; Lecine P; Cusenier A; Mozziconacci MJ; Arnoulet C; Maraninchi D; Gastaut JA; Imbert J; Lafage-Pochitaloff M; Gabert J
Leukemia; 1997 May; 11(5):644-50. PubMed ID: 9180286
[TBL] [Abstract][Full Text] [Related]
7. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11.
Kundu M; Chen A; Anderson S; Kirby M; Xu L; Castilla LH; Bodine D; Liu PP
Blood; 2002 Oct; 100(7):2449-56. PubMed ID: 12239155
[TBL] [Abstract][Full Text] [Related]
8. Core binding factor beta-smooth muscle myosin heavy chain chimeric protein involved in acute myeloid leukemia forms unusual nuclear rod-like structures in transformed NIH 3T3 cells.
Wijmenga C; Gregory PE; Hajra A; Schröck E; Ried T; Eils R; Liu PP; Collins FS
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1630-5. PubMed ID: 8643682
[TBL] [Abstract][Full Text] [Related]
9. Acute myelomonoblastic leukemia carrying the PEBP2beta/MYH11 fusion gene.
Asou N; Osato M; Okubo T; Yamasaki H; Hoshino K; Nishimura S; Era T; Suzushima H; Takatsuki K
Leuk Lymphoma; 1998 Sep; 31(1-2):81-91. PubMed ID: 9720717
[TBL] [Abstract][Full Text] [Related]
10. Cbfbeta reduces Cbfbeta-SMMHC-associated acute myeloid leukemia in mice.
Heilman SA; Kuo YH; Goudswaard CS; Valk PJ; Castilla LH
Cancer Res; 2006 Dec; 66(23):11214-8. PubMed ID: 17145866
[TBL] [Abstract][Full Text] [Related]
11. Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice.
Hyde RK; Zhao L; Alemu L; Liu PP
Leukemia; 2015 Aug; 29(8):1771-8. PubMed ID: 25742748
[TBL] [Abstract][Full Text] [Related]
12. HDAC1 Is a Required Cofactor of CBFβ-SMMHC and a Potential Therapeutic Target in Inversion 16 Acute Myeloid Leukemia.
Richter LE; Wang Y; Becker ME; Coburn RA; Williams JT; Amador C; Hyde RK
Mol Cancer Res; 2019 Jun; 17(6):1241-1252. PubMed ID: 30814129
[TBL] [Abstract][Full Text] [Related]
13. Function of the inv(16) fusion gene CBFB-MYH11.
Kundu M; Liu PP
Curr Opin Hematol; 2001 Jul; 8(4):201-5. PubMed ID: 11561156
[TBL] [Abstract][Full Text] [Related]
14. RUNX1 and CBFβ-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development.
Zhen T; Cao Y; Ren G; Zhao L; Hyde RK; Lopez G; Feng D; Alemu L; Zhao K; Liu PP
Blood; 2020 Nov; 136(21):2373-2385. PubMed ID: 32929473
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of a new variant of the CBF beta-MYH11 gene fusion.
Stulberg J; Kamel-Reid S; Chun K; Tokunaga J; Wells RA
Leuk Lymphoma; 2002 Oct; 43(10):2021-6. PubMed ID: 12481902
[TBL] [Abstract][Full Text] [Related]
16. CBFB/MYH11 fusion in a patient with AML-M4Eo and cytogenetically normal chromosomes 16.
Pirc-Danoewinata H; Dauwerse HG; König M; Chudoba I; Mitterbauer M; Jäger U; Breuning MH; Haas OA
Genes Chromosomes Cancer; 2000 Oct; 29(2):186-91. PubMed ID: 10959099
[TBL] [Abstract][Full Text] [Related]
17. Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemia.
van der Reijden BA; Martinet D; Dauwerse JG; Giles RH; Wessels JW; Beverstock GC; Smit B; Mühlematter D; Jotterand Bellomo M; Gabert J; Lafage-Pochitaloff M; Reiffers J; Bilhou-Nabera C; van Ommen GJ; Hagemeijer A; Breuning MH
Leukemia; 1996 Sep; 10(9):1459-62. PubMed ID: 8751463
[TBL] [Abstract][Full Text] [Related]
18. The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias.
Kuss BJ; Deeley RG; Cole SP; Willman CL; Kopecky KJ; Wolman SR; Eyre HJ; Callen DF
Leuk Lymphoma; 1996 Feb; 20(5-6):357-64. PubMed ID: 8833390
[TBL] [Abstract][Full Text] [Related]
19. Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia.
Richter L; Wang Y; Hyde RK
Oncotarget; 2016 Oct; 7(40):66255-66266. PubMed ID: 27542261
[TBL] [Abstract][Full Text] [Related]
20. NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfβ-SMMHC via activation of MEK/ERK axis.
Xue L; Pulikkan JA; Valk PJ; Castilla LH
Blood; 2014 Jul; 124(3):426-36. PubMed ID: 24894773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]